GILEAD SCIENCES, INC. bought XLO
April 2, 2024 · Form 4 insider transaction
GILEAD SCIENCES, INC. bought 3,882,450 shares of Xilio Therapeutics, Inc. at $0.76 per share, a transaction worth $2.95M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,882,450
Price
$0.76
Total value
$2.95M
InsiderGILEAD SCIENCES, INC.
Role—
SecurityPrefunded Warrants (right to buy)
Transaction codeP: Open-market purchase
Transaction dateApril 2, 2024
Filing dateApril 3, 2024
Shares owned after3,882,450
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Prefunded Warrants have no expiration date and are exercisable at any time on or after the date of issuance. A holder of Prefunded Warrants may not exercise the Prefunded Warrants if, after giving effect to such exercise, the holder and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the outstanding shares of Common Stock of the Issuer.